A Study Of Subscalp Placement Of The LINQII Device

Enrolling by invitation · Not applicable

Conditions studied: Cranial Neurosurgery

In brief

The purpose of this to evaluate the capability of the FDA approved Medtronic LINQ II device (implantable cardiac monitoring device) to record EEG signals when placed temporarily in the subscalp space in patients undergoing cranial neurosurgery. No disease-directed therapeutic efficacy endpoints will be studied.

Key facts

Study ID

NCT07752251

Run by

Mayo Clinic

People needed

10

Starts

2026-11-01

Expected to finish

2027-11-01

Last updated by the study team

2026-08-07

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients 18-80 years old.
• Undergoing (or expected to undergo) intracranial EEG electrode or deep brain stimulator placement surgery as part of clinical standard of care.

You may not qualify if…

• Patients deemed by the neurosurgery team to be at elevated risk of infection or hemorrhage because of the study procedure.
• Individuals who cannot provide informed consent, do not have an available legally authorized representative, or are part of vulnerable or protected populations.
• Pregnant or breast-feeding female participants.
• Women of childbearing potential will be screened prior to surgery following standard of care procedures.

Where it is running

• Mayo Clinic in Arizona — Scottsdale, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.